Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-29

FDA Approved: VALGANCICLOVIR HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)

View source ↗

Summary

The FDA approved a supplemental application to Somerset Therapeutics, LLC for valganciclovir hydrochloride (valganciclovir), authorizing a generic version under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valganciclovir hydrochloride (VALGANCICLOVIR HYDROCHLORIDE)

Snippet

SUPPL AP for VALGANCICLOVIR HYDROCHLORIDE (VALGANCICLOVIR)